Tuberculosis Incidence in Prisons: A Systematic Review
Background:
Transmission of tuberculosis (TB) in prisons has been reported worldwide to be much higher than that reported for the corresponding general population.
Methods and Findings:
A systematic review has been performed to assess the risk of incident latent tuberculosis infection (LTBI) and TB disease in prisons, as compared to the incidence in the corresponding local general population, and to estimate the fraction of TB in the general population attributable (PAF%) to transmission within prisons. Primary peer-reviewed studies have been searched to assess the incidence of LTBI and/or TB within prisons published until June 2010; both inmates and prison staff were considered. Studies, which were independently screened by two reviewers, were eligible for inclusion if they reported the incidence of LTBI and TB disease in prisons. Available data were collected from 23 studies out of 582 potentially relevant unique citations. Five studies from the US and one from Brazil were available to assess the incidence of LTBI in prisons, while 19 studies were available to assess the incidence of TB. The median estimated annual incidence rate ratio (IRR) for LTBI and TB were 26.4 (interquartile range [IQR]: 13.0–61.8) and 23.0 (IQR: 11.7–36.1), respectively. The median estimated fraction (PAF%) of tuberculosis in the general population attributable to the exposure in prisons for TB was 8.5% (IQR: 1.9%–17.9%) and 6.3% (IQR: 2.7%–17.2%) in high- and middle/low-income countries, respectively.
Conclusions:
The very high IRR and the substantial population attributable fraction show that much better TB control in prisons could potentially protect prisoners and staff from within-prison spread of TB and would significantly reduce the national burden of TB. Future studies should measure the impact of the conditions in prisons on TB transmission and assess the population attributable risk of prison-to-community spread.
: Please see later in the article for the Editors' Summary
Vyšlo v časopise:
Tuberculosis Incidence in Prisons: A Systematic Review. PLoS Med 7(12): e32767. doi:10.1371/journal.pmed.1000381
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.pmed.1000381
Souhrn
Background:
Transmission of tuberculosis (TB) in prisons has been reported worldwide to be much higher than that reported for the corresponding general population.
Methods and Findings:
A systematic review has been performed to assess the risk of incident latent tuberculosis infection (LTBI) and TB disease in prisons, as compared to the incidence in the corresponding local general population, and to estimate the fraction of TB in the general population attributable (PAF%) to transmission within prisons. Primary peer-reviewed studies have been searched to assess the incidence of LTBI and/or TB within prisons published until June 2010; both inmates and prison staff were considered. Studies, which were independently screened by two reviewers, were eligible for inclusion if they reported the incidence of LTBI and TB disease in prisons. Available data were collected from 23 studies out of 582 potentially relevant unique citations. Five studies from the US and one from Brazil were available to assess the incidence of LTBI in prisons, while 19 studies were available to assess the incidence of TB. The median estimated annual incidence rate ratio (IRR) for LTBI and TB were 26.4 (interquartile range [IQR]: 13.0–61.8) and 23.0 (IQR: 11.7–36.1), respectively. The median estimated fraction (PAF%) of tuberculosis in the general population attributable to the exposure in prisons for TB was 8.5% (IQR: 1.9%–17.9%) and 6.3% (IQR: 2.7%–17.2%) in high- and middle/low-income countries, respectively.
Conclusions:
The very high IRR and the substantial population attributable fraction show that much better TB control in prisons could potentially protect prisoners and staff from within-prison spread of TB and would significantly reduce the national burden of TB. Future studies should measure the impact of the conditions in prisons on TB transmission and assess the population attributable risk of prison-to-community spread.
: Please see later in the article for the Editors' Summary
Zdroje
1. AngieB
AnnA
MalgosiaG
MichaelK
HansK
2000 Tuberculosis control in prisons: A Manual for Programme Managers. Geneva World Health Organization
2. DaraM
GrzemskaM
KimerlingME
ReyesH
ZagorskiyA
2009 Guidelines for control of tuberculosis in prisons. The Global Health Bureau, Office of Health, Infectious Disease and Nutrition (HIDN), US Agency for International Development
3. ReyesH
ConinxR
1997 Pitfalls of tuberculosis programmes in prisons. BMJ 315 1447 1450
4. StucklerD
BasuS
McKeeM
KingL
2008 Mass incarceration can explain population increases in TB and multidrug-resistant TB in European and central Asian countries. Proc Natl Acad Sci U S A 105 13280 13285
5. NiveauG
2006 Prevention of infectious disease transmission in correctional settings: a review. Public Health 120 33 41
6. JensenPA
LambertLA
IademarcoMF
RidzonR
2005 Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care settings, 2005. MMWR Recomm Rep 54 1 141
7. World Health Organization Global Health Atlas. Available: http://www.who.int/globalatlas/dataQuery/default.asp. Accessed 19 November 2010
8. HigginsJP
ThompsonSG
DeeksJJ
AltmanDG
2003 Measuring inconsistency in meta-analyses. BMJ 327 557 560
9. LevinML
1953 The occurrence of lung cancer in man. Acta Unio Int Contra Cancrum 9 531 541
10. United Nations Development Programme 2008 New York, USA Human Development Report
11. WalmsleyR
2009 World Prison Population List (8th edition). London International Centre for Prison Studies, King's College
12. World Bank 2008 World Bank Country Classification. Available: http://www.worldbank.org/data/countryclass/classgroups.htm. Accessed 19 November 2010
13. WellsG
SheaB
O'ConnellD
PetersonJ
WelchV
The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Available: http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp. Accessed 16 November 2010
14. ChavesF
DrondaF
CaveMD
Alonso-SanzM
Gonzalez-LopezA
1997 A longitudinal study of transmission of tuberculosis in a large prison population. Am J Respir Crit Care Med 155 719 725
15. Fernandez de la HozK
InigoJ
Fernandez-MartinJI
ArceA
Alonso-SanzM
2001 The influence of HIV infection and imprisonment on dissemination of Mycobacterium tuberculosis in a large Spanish city. Int J Tuberc Lung Dis 5 696 702
16. FerreiraMM
FerrazoliL
PalaciM
SallesPS
MedeirosLA
1996 Tuberculosis and HIV infection among female inmates in Sao Paulo, Brazil: a prospective cohort study. J Acquir Immune Defic Syndr Hum Retrovirol 13 177 183
17. Hanau-BercotB
GremyI
RaskineL
BizetJ
GutierrezMC
2000 A one-year prospective study (1994–1995) for a first evaluation of tuberculosis transmission in French prisons. Int J Tuberc Lung Dis 4 853 859
18. HungR
SheltonS
RischitelliG
2002 Risk factors for tuberculosis conversion in a state prison. McGill J Med 7 26 31
19. IjazK
YangZ
TempletonG
SteadWW
BatesJH
2004 Persistence of a strain of Mycobacterium tuberculosis in a prison system. Int J Tuberc Lung Dis 8 994 1000
20. JonesTF
CraigAS
ValwaySE
WoodleyCL
SchaffnerW
1999 Transmission of tuberculosis in a jail. Ann Intern Med 131 557 563
21. KlopfLC
1998 Tuberculosis control in the New York State Department of Correctional Services: a case management approach. Am J Infect Control 26 534 537
22. KoffiN
NgomAK
Aka-DanguyE
SekaA
AkotoA
1997 Smear positive pulmonary tuberculosis in a prison setting: experience in the penal camp of Bouake, Ivory Coast. Int J Tuberc Lung Dis 1 250 253
23. KooDT
BaronRC
RutherfordGW
1997 Transmission of Mycobacterium tuberculosis in a California State Prison, 1991. Am J Public Health 87 279 282
24. MacIntyreCR
KendigN
KummerL
BiragoS
GrahamNM
1997 Impact of tuberculosis control measures and crowding on the incidence of tuberculous infection in Maryland prisons. Clin Infect Dis 24 1060 1067
25. MarchF
CollP
GuerreroRA
BusquetsE
CaylaJA
2000 Predictors of tuberculosis transmission in prisons: an analysis using conventional and molecular methods. AIDS 14 525 535
26. MartinV
GuerraJM
CaylaJA
RodriguezJC
BlancoMD
2001 Incidence of tuberculosis and the importance of treatment of latent tuberculosis infection in a Spanish prison population. Int J Tuberc Lung Dis 5 926 932
27. MitchellCS
GershonRR
LearsMK
VlahovD
FelknorS
2005 Risk of tuberculosis in correctional healthcare workers. J Occup Environ Med 47 580 586
28. MorZ
AdlerA
LeventhalA
VolovicI
RosenfeldE
2008 Tuberculosis behind bars in Israel: policy making within a dynamic situation. Isr Med Assoc J 10 202 206
29. SlavuckijA
SizaireV
LoberaL
MatthysF
KimerlingME
2002 Decentralization of the DOTS programme within a Russian penitentiary system. How to ensure the continuity of tuberculosis treatment in pre-trial detention centres. Eur J Public Health 12 94 98
30. SteenlandK
LevineAJ
SieberK
SchulteP
AzizD
1997 Incidence of tuberculosis infection among New York State prison employees. Am J Public Health 87 2012 2014
31. ValwaySE
RichardsSB
KovacovichJ
GreifingerRB
CrawfordJT
1994 Outbreak of multi-drug-resistant tuberculosis in a New York State prison, 1991. Am J Epidemiol 140 113 122
32. WongMY
LeungCC
TamCM
KamKM
MaCH
2008 TB surveillance in correctional institutions in Hong Kong, 1999–2005. Int J Tuberc Lung Dis 12 93 98
33. BraunMM
TrumanBI
MaguireB
DiFerdinandoGTJr
WormserG
1989 Increasing incidence of tuberculosis in a prison inmate population. Association with HIV infection. JAMA 261 393 397
34. de OliveiraHB
CardosoJC
2004 [Tuberculosis among city jail inmates in Campinas, Sao Paulo, Brazil]. Rev Panam Salud Publica 15 194 199
35. RusskikhOE
2007 [Comparative analysis of tuberculosis morbidity trends in the penitentiary and civil health care systems of the Udmurt Republic over 10 years]. Probl Tuberk Bolezn Legk 38 39
36. Pavlov IuA
PungaVV
2003 [Organization of tuberculosis-controlling work and its efficiency in the penitentiaries of the Ivanovo Region]. Probl Tuberk Bolezn Legk 3 5
37. AertsA
HauerB
WanlinM
VeenJ
2006 Tuberculosis and tuberculosis control in European prisons. Int J Tuberc Lung Dis 10 1215 1223
38. ZarateE
LobónI
SaavedraC
CastañedaM
2005 [Tuberculosis new scenery: prison establishments]. An Fac Med Lima 66 148 158
39. KimerlingM
2006 Tuberculosis in Prisons.
RaviglioneM
Reichman and Hershfield's Tuberculosis: A Comprehensive International Approach. 3rd ed New York Informa Healthcare 921 948
40. MatthysF
RigoutsL
SizaireV
VezhninaN
LecoqM
2009 Outcomes after chemotherapy with WHO category II regimen in a population with high prevalence of drug resistant tuberculosis. PLoS One 4 e7954 doi:10.1371/journal.pone.0007954
41. ConinxR
MaherD
ReyesH
GrzemskaM
2000 Tuberculosis in prisons in countries with high prevalence. BMJ 320 440 442
42. ScanoF
2009 WHO policy on TB infection control in health-care facilities, congregate settings and households. Geneva, Switzerland World Health Organization
43. LarouzeB
SanchezA
DiuanaV
2008 Tuberculosis behind bars in developing countries: a hidden shame to public health. Trans R Soc Trop Med Hyg 102 841 842
44. ArshadS
BavanL
GajariK
PagetSN
BaussanoI
2009 Active screening at entry for tuberculosis among new immigrants: a systematic review and meta-analysis. Eur Respir J 35 1336 1345
45. JoshiR
ReingoldAL
MenziesD
PaiM
2006 Tuberculosis among health-care workers in low- and middle-income countries: a systematic review. PLoS Med 3 e494 doi:10.1371/journal.pmed.0030494
46. LobachevaT
SazhinV
VdovichenkoE
GieseckeJ
2005 Pulmonary tuberculosis in two remand prisons (SIZOs) in St Petersburg, Russia. Euro Surveill 10 93 96
47. United Nations DevelopmentProgramme 2009 New York, USA Human Development Report 2009
48. RodrigoT
CaylaJA
Garcia de OlallaP
BrugalMT
JansaJM
2002 Effectiveness of tuberculosis control programmes in prisons, Barcelona 1987–2000. Int J Tuberc Lung Dis 6 1091 1097
49. MenziesD
JoshiR
PaiM
2007 Risk of tuberculosis infection and disease associated with work in health care settings. Int J Tuberc Lung Dis 11 593 605
Štítky
Interné lekárstvoČlánok vyšiel v časopise
PLOS Medicine
2010 Číslo 12
- Statinová intolerance
- Očkování proti virové hemoragické horečce Ebola experimentální vakcínou rVSVDG-ZEBOV-GP
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
- Metamizol v liečbe pooperačnej bolesti u detí do 6 rokov veku
- Co dělat při intoleranci statinů?
Najčítanejšie v tomto čísle
- Clinical Features and Serum Biomarkers in HIV Immune Reconstitution Inflammatory Syndrome after Cryptococcal Meningitis: A Prospective Cohort Study
- Participatory Epidemiology: Use of Mobile Phones for Community-Based Health Reporting
- Scaling Up the 2010 World Health Organization HIV Treatment Guidelines in Resource-Limited Settings: A Model-Based Analysis
- Toward a Consensus on Guiding Principles for Health Systems Strengthening